Compare Super Micro Computer Inc (SMCI) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Super Micro Computer Inc vs BIO-TECHNE Corp — how do they compare? Super Micro Computer Inc trades at $33.95 (market cap $20.35B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: Super Micro Computer Inc is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Super Micro Computer Inc pays none. Which is the better fit depends on your goals.
| SMCI | TECH | |
|---|---|---|
Market Cap | $20.35B | $11.24B |
Sector | Technology | Health |
52-Week High | $58.68 | $72.29 |
52-Week Low | $20.53 | $43.31 |
Enterprise Value | $27.87B | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Super Micro Computer (SMCI) trades at $31.13, up 5.96% on the day, with a bullish technical signal from moving averages. The stock shows strong fundamental metrics with a P/E of 16.56 and P/S of 0.62, while recent earnings have beaten expectations. Revenue growth remains robust, reaching $21.97B in 2025, though net margins compressed to 3.7%. Analyst consensus is mixed with a $39.20 price target, representing 26% upside potential from current levels.
The outlook for SMCI hinges on execution of its massive $60B AI server order backlog and margin expansion to 15-17% guidance. Key risks include working capital strain with negative operating cash flow projected for 2026 and high dependence on Nvidia components. While valuation appears attractive, investors should monitor the company's ability to convert orders into profitable growth amid intense AI infrastructure competition.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Super Micro Computer Inc
Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
